scispace - formally typeset
G

Glenn M. Chertow

Researcher at Stanford University

Publications -  830
Citations -  94517

Glenn M. Chertow is an academic researcher from Stanford University. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 128, co-authored 764 publications receiving 82401 citations. Previous affiliations of Glenn M. Chertow include University of Groningen & Fresenius Medical Care.

Papers
More filters
Journal ArticleDOI

Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance

TL;DR: This work modeled 245 hemodialysis sessions in 210 patients enrolled in the Frequent Hemodialysis Network Daily and Nocturnal clinical trials and predicted standard Kt/V with a high level of accuracy, even when substantial fluid removal and residual urea clearance were present.
Journal ArticleDOI

Utilization of Renal Mass Biopsy in Patients With Renal Cell Carcinoma

TL;DR: Most patients whoEventually undergo radical or partial nephrectomy do not undergo RMB, whereas most patients who eventually undergo ablation or systemic therapy do, and the optimal use of RMB in the evaluation of kidney tumors has yet to be determined.
Journal ArticleDOI

Intensity of renal support in critically ill patients with acute kidney injury (New England Journal of Medicine (2008) 359, (7-20))

Paul M. Palevsky, +207 more
Journal ArticleDOI

Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.

TL;DR: In this paper, the authors used Poisson regression to evaluate risk factors for absent or attenuated response to vaccination, and found that 22% of patients receiving dialysis had suboptimal responses to vaccination irrespective of whether they had evidence of prior SARS-CoV-2 infection.